Cabaletta Bio Inc. has appointed Anup Marda, MBA, as Chief Financial Officer effective immediately. Mr. Marda joins Cabaletta with 17 years of financial leadership experience, most recently as Vice President and Head of Global Corporate Financial Planning Analysis of Bristol-Myers Squibb (BMS). Previously, Mr. Marda spent four years in leadership roles supporting R D, including leading a team responsible for providing financial and business support for multiple groups, including: Discovery, Translational Medicine, Pharmaceutical Development, Global Clinical Operations, Global Regulatory, Operations and Global Medical.